Chlamydia trachomatis infection is the most prevalent bacterial sexually transmitted 27 infection and can cause significant reproductive morbidity in women. There is 28 insufficient knowledge of C. trachomatis-specific immune responses in humans, which 29 could be important in guiding vaccine development efforts. 
Chlamydia trachomatis, an obligate intracellular bacterium, causes mucosal infection 48 (chlamydia) of the genital, anorectal, and oropharyngeal surfaces in humans. Chlamydia 49 is the most prevalent bacterial sexually transmitted infection (STI) worldwide (1), and 50 genital chlamydia is associated with significant reproductive morbidity, including tubal 51 factor infertility. Despite over two decades of national screening efforts in the U.S., the 52 prevalence of chlamydia continues to rise (2). Availability of a chlamydia vaccine could 53 improve chlamydia prevention efforts (3, 4), but vaccine development efforts have been 54 hindered in part by insufficient knowledge of the immune responses to C. trachomatis 55 infection in humans that contribute to protective immunity (5). 56
Because of the ethical concerns in performing Chlamydia challenge or natural 57 history studies in humans, animal models have played a critical role in identifying the 58 mechanisms of protective immunity to chlamydia (6). In murine models of genital 59 chlamydia, protective immunity is largely mediated through CD4 + T helper type 1 (Th1) 60 cell responses, with interferon-gamma (IFN-γ) playing an essential role (7). Another Th1 61 cytokine, tumor necrosis factor alpha (TNF-α), has also been implicated in protective 62 immunity to chlamydia in murine studies (8-10). TNF-α is a pleiotropic proinflammatory 63 cytokine released from monocytes, macrophages, and lymphocytes that stimulates a 64 cascade of other cytokines (11). In the murine chlamydia model, the influence of TNF-α 65
on chlamydia clearance appears to be specific to the mucosal site infected. For 66 example, in the mouse pneumonitis model (which uses C. muridarum), TNF-α deletion 67 significantly accelerates mortality and increases organism burden in the lung (8, 9), 68 suggesting a protective role for TNF-α. However, TNF-α depletion seems to have no 69 effect on C. muridarum clearance from the genital tract (12) (13) (14) 
RESULTS

181
Ninety women with chlamydia infection at the time of enrollment were investigated in 182 this study (Table 1 ). The median age was 21 (range 16 -32), 97% were African 183 American, and 1% were Hispanic. 54% of women were asymptomatic and 40% were 184 diagnosed with co-infections bacterial vaginosis, trichomoniasis, or vaginal candidiasis. 185 57% of women had a prior history of chlamydia, based on self-report and/or 186 documentation of prior positive chlamydia test results. 187
Of the three Th1 cytokines tested, the predominant CD4 + cytokine elicited by 188 stimulated PBMCs from chlamydia-infected women was TNF-α, not IFN-γ. a chlamydia-infected subject and a chlamydia-negative control subject. As shown in Fig.  214 2B, all three antigens generated predominantly CD4 + TNF-α qualitative responses, but 215 these responses were most often generated with Pgp3 stimulation when compared with 216 stimulation with MOMP (64% vs. 34%; P <0.001) or EB (64% vs. 51%; P = 0.035). The 217 proportion of women with a positive CD4 + TNF-α response to EB was significantly 218 higher than to MOMP (51% vs. 34%; P = 0.011). There was no significant difference in 13% to EB only, and 3% to MOMP only (Fig. 4) . With murine chlamydia models convincingly demonstrating the importance of Th1 286
CD4
+ IFN-γ in chlamydia infection clearance (7) and some animal studies demonstrating 287 a potential protective role for TNF-α (8, 33), our study sought to increase our 288 
